Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing

OBJECTIVES: The objective of this study is to explore the characteristics of the subset of patients with hematologic malignancies (HMs) who had little to no change in SARS-CoV-2 spike antibody index value levels after a third mRNA vaccine dose (3V) and to compare the cohort of patients who did and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallmeyer, Sigrun, Thompson, Michael A, Fitzpatrick, Veronica, Liao, Yunqi, Mullane, Michael P, Medlin, Stephen C, Copeland, Kenneth, Weese, James L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Special Collection: Covid19 Methods & Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982360/
https://www.ncbi.nlm.nih.gov/pubmed/36873569
http://dx.doi.org/10.1093/biomethods/bpad002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982360/
https://www.ncbi.nlm.nih.gov/pubmed/36873569
http://dx.doi.org/10.1093/biomethods/bpad002

Ejemplares similares